Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Symrise, S. de R.L de C.V.
483
•Symrise, S. de R.L de C.V.•September 21, 2018

Symrise, S. de R.L de C.V. – FDA 483, Sep 21, 2018

Record Details

The FDA conducted an inspection of Symrise, S. de R.L. de C.V., a manufacturing facility located in San Nicolas de los Garza, Nuevo Leon, Mexico, from July 17 to July 22, 2018. The inspection identified several significant compliance issues related to quality control and manufacturing processes. Key observations included a lack of oversight by the Quality Unit over document control, specifically in the issuance of batch and production control records. Additionally, there were no established written procedures for production and process controls to ensure drug products meet required identity, strength, quality, and purity standards. The facility also failed to conduct necessary process validations for drug manufacturing, including documenting the number of process repetitions for active pharmaceutical ingredients (APIs).

Furthermore, deficiencies were noted in batch production and control records, which did not accurately reflect the master production records. Laboratory controls were inadequate, lacking scientifically sound standards and procedures for testing and validation, such as the cleaning validation protocol and calibration of laboratory equipment.

The FDA's observations highlight the need for Symrise to implement corrective actions to address these compliance issues. The company is responsible for conducting internal audits to identify and rectify all violations of quality system requirements. Symrise is expected to develop and enforce comprehensive written procedures, ensure proper documentation, and establish scientifically sound laboratory controls to comply with regulatory standards.

Company
Symrise, S. de R.L de C.V.
Inspection date
September 21, 2018
Product type
Drugs
Office
Office of Pharmaceutical Quality
Person
  • Kara Dobbin
View Company Profile

ID · 7139edbd-5b83-462c-973b-62d468f1848d

Other documents for Symrise, S. de R.L de C.V.
  • 483 - 2025-05-23May 23, 2025

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Symrise, S. de R.L de C.V.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.